Literature DB >> 31144615

Sleep problems and associations with psychopathology and cognition in young people with 22q11.2 deletion syndrome (22q11.2DS).

H A Moulding1, U Bartsch2,3, J Hall1,4, M W Jones2, D E Linden1,5, M J Owen1, M B M van den Bree1.   

Abstract

BACKGROUND: Young people with 22q11.2 deletion syndrome (22q11.2DS) are at high risk for neurodevelopmental disorders. Sleep problems may play a role in this risk but their prevalence, nature and links to psychopathology and cognitive function remain undescribed in this population.
METHOD: Sleep problems, psychopathology, developmental coordination and cognitive function were assessed in 140 young people with 22q11.2DS (mean age = 10.1, s.d. = 2.46) and 65 unaffected sibling controls (mean age = 10.8, s.d.SD = 2.26). Primary carers completed questionnaires screening for the children's developmental coordination and autism spectrum disorder.
RESULTS: Sleep problems were identified in 60% of young people with 22q11.2DS compared to 23% of sibling controls (OR 5.00, p < 0.001). Two patterns best-described sleep problems in 22q11.2DS: restless sleep and insomnia. Restless sleep was linked to increased ADHD symptoms (OR 1.16, p < 0.001) and impaired executive function (OR 0.975, p = 0.013). Both patterns were associated with elevated symptoms of anxiety disorder (restless sleep: OR 1.10, p = 0.006 and insomnia: OR 1.07, p = 0.045) and developmental coordination disorder (OR 0.968, p = 0.0023, and OR 0.955, p = 0.009). The insomnia pattern was also linked to elevated conduct disorder symptoms (OR 1.53, p = 0.020).
CONCLUSIONS: Clinicians and carers should be aware that sleep problems are common in 22q11.2DS and index psychiatric risk, cognitive deficits and motor coordination problems. Future studies should explore the physiology of sleep and the links with the neurodevelopment in these young people.

Entities:  

Keywords:  22q11.2 Deletion syndrome; ADHD; anxiety; children; cognition; melatonin; neurodevelopment; paediatric sleep; psychopathology; sleep; young people

Mesh:

Year:  2019        PMID: 31144615     DOI: 10.1017/S0033291719001119

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   10.592


  8 in total

1.  Selective Effects of Methylphenidate on Attention and Inhibition in 22q11.2 Deletion Syndrome: Results From a Clinical Trial.

Authors:  Johanna Maeder; Valentina Mancini; Corrado Sandini; Fiona Journal; Maude Schneider; Matthias Kliegel; Stephan Eliez
Journal:  Int J Neuropsychopharmacol       Date:  2022-03-17       Impact factor: 5.176

Review 2.  Developmental Coordination Disorder and Most Prevalent Comorbidities: A Narrative Review.

Authors:  Federica Lino; Daniela Pia Rosaria Chieffo
Journal:  Children (Basel)       Date:  2022-07-21

3.  Sleep EEG in young people with 22q11.2 deletion syndrome: A cross-sectional study of slow-waves, spindles and correlations with memory and neurodevelopmental symptoms.

Authors:  Nicholas A Donnelly; Ullrich Bartsch; Marianne B M van den Bree; Matt W Jones; Hayley A Moulding; Christopher Eaton; Hugh Marston; Jessica H Hall; Jeremy Hall; Michael J Owen
Journal:  Elife       Date:  2022-08-30       Impact factor: 8.713

4.  Copy number variation at the 22q11.2 locus influences prevalence, severity, and psychiatric impact of sleep disturbance.

Authors:  Kathleen P O'Hora; Amy Lin; Leila Kushan-Wells; Carrie E Bearden
Journal:  J Neurodev Disord       Date:  2022-07-10       Impact factor: 4.074

5.  Analysis of genes within the schizophrenia-linked 22q11.2 deletion identifies interaction of night owl/LZTR1 and NF1 in GABAergic sleep control.

Authors:  Gianna W Maurer; Alina Malita; Stanislav Nagy; Takashi Koyama; Thomas M Werge; Kenneth A Halberg; Michael J Texada; Kim Rewitz
Journal:  PLoS Genet       Date:  2020-04-27       Impact factor: 5.917

Review 6.  Consequences of 22q11.2 Microdeletion on the Genome, Individual and Population Levels.

Authors:  Małgorzata Karbarz
Journal:  Genes (Basel)       Date:  2020-08-22       Impact factor: 4.096

7.  Assessment of emotions and behaviour by the Developmental Behaviour Checklist in young people with neurodevelopmental CNVs.

Authors:  Adam C Cunningham; Jeremy Hall; Stewart Einfeld; Michael J Owen; Marianne B M van den Bree
Journal:  Psychol Med       Date:  2020-07-09       Impact factor: 7.723

Review 8.  Effects of copy number variations on brain structure and risk for psychiatric illness: Large-scale studies from the ENIGMA working groups on CNVs.

Authors:  Ida E Sønderby; Christopher R K Ching; Sophia I Thomopoulos; Dennis van der Meer; Daqiang Sun; Julio E Villalon-Reina; Ingrid Agartz; Katrin Amunts; Celso Arango; Nicola J Armstrong; Rosa Ayesa-Arriola; Geor Bakker; Anne S Bassett; Dorret I Boomsma; Robin Bülow; Nancy J Butcher; Vince D Calhoun; Svenja Caspers; Eva W C Chow; Sven Cichon; Simone Ciufolini; Michael C Craig; Benedicto Crespo-Facorro; Adam C Cunningham; Anders M Dale; Paola Dazzan; Greig I de Zubicaray; Srdjan Djurovic; Joanne L Doherty; Gary Donohoe; Bogdan Draganski; Courtney A Durdle; Stefan Ehrlich; Beverly S Emanuel; Thomas Espeseth; Simon E Fisher; Tian Ge; David C Glahn; Hans J Grabe; Raquel E Gur; Boris A Gutman; Jan Haavik; Asta K Håberg; Laura A Hansen; Ryota Hashimoto; Derrek P Hibar; Avram J Holmes; Jouke-Jan Hottenga; Hilleke E Hulshoff Pol; Maria Jalbrzikowski; Emma E M Knowles; Leila Kushan; David E J Linden; Jingyu Liu; Astri J Lundervold; Sandra Martin-Brevet; Kenia Martínez; Karen A Mather; Samuel R Mathias; Donna M McDonald-McGinn; Allan F McRae; Sarah E Medland; Torgeir Moberget; Claudia Modenato; Jennifer Monereo Sánchez; Clara A Moreau; Thomas W Mühleisen; Tomas Paus; Zdenka Pausova; Carlos Prieto; Anjanibhargavi Ragothaman; Céline S Reinbold; Tiago Reis Marques; Gabriela M Repetto; Alexandre Reymond; David R Roalf; Borja Rodriguez-Herreros; James J Rucker; Perminder S Sachdev; James E Schmitt; Peter R Schofield; Ana I Silva; Hreinn Stefansson; Dan J Stein; Christian K Tamnes; Diana Tordesillas-Gutiérrez; Magnus O Ulfarsson; Ariana Vajdi; Dennis van 't Ent; Marianne B M van den Bree; Evangelos Vassos; Javier Vázquez-Bourgon; Fidel Vila-Rodriguez; G Bragi Walters; Wei Wen; Lars T Westlye; Katharina Wittfeld; Elaine H Zackai; Kári Stefánsson; Sebastien Jacquemont; Paul M Thompson; Carrie E Bearden; Ole A Andreassen
Journal:  Hum Brain Mapp       Date:  2021-02-21       Impact factor: 5.399

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.